Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Change of body weight and macrophage inhibitory cytokine-1 during chemotherapy in advanced gastric cancer: what is their clinical significance?

Lu Z, Yang L, Yu J, Lu M, Zhang X, Li J, Zhou J, Wang X, Gong J, Gao J, Li J, Li Y, Shen L.

PLoS One. 2014 Feb 28;9(2):e88553. doi: 10.1371/journal.pone.0088553. eCollection 2014.

PMID:
24586342
[PubMed - in process]
Free PMC Article
2.

Weight loss correlates with macrophage inhibitory cytokine-1 expression and might influence outcome in patients with advanced esophageal squamous cell carcinoma.

Lu ZH, Yang L, Yu JW, Lu M, Li J, Zhou J, Wang XC, Gong JF, Gao J, Zhang XT, Li J, Li Y, Shen L.

Asian Pac J Cancer Prev. 2014;15(15):6047-52.

PMID:
25124572
[PubMed - in process]
Free Article
3.

Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer.

Hwang JE, Kim HN, Kim DE, Choi HJ, Jung SH, Shim HJ, Bae WK, Hwang EC, Cho SH, Chung IJ.

BMC Cancer. 2011 Nov 21;11:489. doi: 10.1186/1471-2407-11-489.

PMID:
22103888
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy.

Li QQ, Lu ZH, Yang L, Lu M, Zhang XT, Li J, Zhou J, Wang XC, Gong JF, Gao J, Li J, Li Y, Shen L.

Asian Pac J Cancer Prev. 2014;15(2):945-50.

PMID:
24568523
[PubMed - in process]
Free Article
5.

Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin.

Saito K, Urakami S, Komai Y, Yasuda Y, Kubo Y, Kitsukawa S, Okubo Y, Yamamoto S, Yonese J, Fukui I.

BJU Int. 2012 Nov;110(10):1478-84. doi: 10.1111/j.1464-410X.2012.11153.x. Epub 2012 Apr 23.

PMID:
22520732
[PubMed - indexed for MEDLINE]
6.

Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer.

Skipworth RJ, Deans DA, Tan BH, Sangster K, Paterson-Brown S, Brown DA, Hunter M, Breit SN, Ross JA, Fearon KC.

Br J Cancer. 2010 Feb 16;102(4):665-72. doi: 10.1038/sj.bjc.6605532. Epub 2010 Jan 26.

PMID:
20104227
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer.

Bilici A, Ustaalioglu BB, Ercan S, Seker M, Yilmaz BE, Orcun A, Gumus M.

Tumour Biol. 2012 Dec;33(6):2201-8. doi: 10.1007/s13277-012-0481-5. Epub 2012 Aug 14.

PMID:
22890829
[PubMed - indexed for MEDLINE]
8.

Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study.

Hess LM, Barakat R, Tian C, Ozols RF, Alberts DS.

Gynecol Oncol. 2007 Nov;107(2):260-5. Epub 2007 Aug 6.

PMID:
17675142
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation.

Dostálová I, Kaválková P, Papezová H, Domluvilová D, Zikán V, Haluzík M.

Nutr Metab (Lond). 2010 Apr 23;7:34. doi: 10.1186/1743-7075-7-34.

PMID:
20416056
[PubMed]
Free PMC Article
10.

Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.

Haas M, Heinemann V, Kullmann F, Laubender RP, Klose C, Bruns CJ, Holdenrieder S, Modest DP, Schulz C, Boeck S.

J Cancer Res Clin Oncol. 2013 Apr;139(4):681-9. doi: 10.1007/s00432-012-1371-3. Epub 2013 Jan 13.

PMID:
23315099
[PubMed - indexed for MEDLINE]
12.

Hyperinsulinemia acutely increases serum macrophage inhibitory cytokine-1 concentration in anorexia nervosa and obesity.

Karczewska-Kupczewska M, Kowalska I, Nikolajuk A, Adamska A, Otziomek E, Gorska M, Straczkowski M.

Clin Endocrinol (Oxf). 2012 Jan;76(1):46-50. doi: 10.1111/j.1365-2265.2011.04139.x.

PMID:
21645023
[PubMed - indexed for MEDLINE]
13.

The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment.

Lindenmann J, Fink-Neuboeck N, Koesslbacher M, Pichler M, Stojakovic T, Roller RE, Maier A, Anegg U, Smolle J, Smolle-Juettner FM.

J Surg Oncol. 2014 Jun 29. doi: 10.1002/jso.23711. [Epub ahead of print]

PMID:
24975677
[PubMed - as supplied by publisher]
14.

C-reactive protein as a monitor of chemotherapy response in advanced non-small cell lung cancer (CML study).

Srimuninnimit V, Ariyapanya S, Nimmannit A, Wonglaksanapimon S, Akewanlop C, Soparattanapaisarn N.

J Med Assoc Thai. 2012 Feb;95 Suppl 2:S199-207.

PMID:
22574550
[PubMed - indexed for MEDLINE]
15.

Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study.

Inal A, Kos FT, Algin E, Yildiz R, Berk V, Tugba Unek I, Colak D, Colak D, Kucukoner M, Tamer Elkiran E, Helvaci K, Geredeli C, Dane F, Balakan O, Ali Kaplan M, Gok Durnali A, Harputoglu H, Goksel G, Ozdemir N, Buyukberber S, Gumus M, Ozkan M, Benekli M, Isikdogan A; Anatolian Society Of Medical Oncology.

J BUON. 2012 Jan-Mar;17(1):102-5.

PMID:
22517701
[PubMed - indexed for MEDLINE]
16.

Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease.

Breit SN, Carrero JJ, Tsai VW, Yagoutifam N, Luo W, Kuffner T, Bauskin AR, Wu L, Jiang L, Barany P, Heimburger O, Murikami MA, Apple FS, Marquis CP, Macia L, Lin S, Sainsbury A, Herzog H, Law M, Stenvinkel P, Brown DA.

Nephrol Dial Transplant. 2012 Jan;27(1):70-5. doi: 10.1093/ndt/gfr575. Epub 2011 Sep 22.

PMID:
21940482
[PubMed - indexed for MEDLINE]
Free Article
17.

Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1.

Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR, Wu L, Pankhurst G, Jiang L, Junankar S, Hunter M, Fairlie WD, Lee NJ, Enriquez RF, Baldock PA, Corey E, Apple FS, Murakami MM, Lin EJ, Wang C, During MJ, Sainsbury A, Herzog H, Breit SN.

Nat Med. 2007 Nov;13(11):1333-40. Epub 2007 Nov 4.

PMID:
17982462
[PubMed - indexed for MEDLINE]
18.

Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet.

Dostálová I, Roubícek T, Bártlová M, Mráz M, Lacinová Z, Haluzíková D, Kaválková P, Matoulek M, Kasalicky M, Haluzík M.

Eur J Endocrinol. 2009 Sep;161(3):397-404. doi: 10.1530/EJE-09-0417. Epub 2009 Jun 10.

PMID:
19515791
[PubMed - indexed for MEDLINE]
Free Article
19.

Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.

Lee S, Oh SY, Kim SH, Lee JH, Kim MC, Kim KH, Kim HJ.

BMC Cancer. 2013 Jul 22;13:350. doi: 10.1186/1471-2407-13-350.

PMID:
23876227
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy.

Jin H, Zhang G, Liu X, Liu X, Chen C, Yu H, Huang X, Zhang Q, Yu J.

World J Surg Oncol. 2013 May 24;11:112. doi: 10.1186/1477-7819-11-112.

PMID:
23705622
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk